Showing results (851-860 of 888) with videos related to

Sort By:
Pageof 89
The Journal of Prevention of Alzheimer'S Disease|December 2, 2025
Donanemab in early symptomatic Alzheimer's disease: results from the TRAILBLAZER-ALZ 2 long-term extensionJennifer A Zimmer, John R Sims, Cynthia D Evans, et al.
Molecular Metabolism|May 25, 2025
Training-induced plasma miR-29a-3p is secreted by skeletal muscle and contributes to metabolic adaptations to resistance exercise in micePaola Pinto-Hernandez, Manuel Fernandez-Sanjurjo, Daan Paget, et al.
Plos Pathogens|July 18, 2022
Caspase-1-driven neutrophil pyroptosis and its role in host susceptibility to Pseudomonas aeruginosaKarin Santoni, David Pericat, Leana Gorse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2019
ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor MicroenvironmentMagnus T Dillon, Katharina F Bergerhoff, Malin Pedersen, et al.
Nucleic Acids Research|October 31, 2021
Phospho-Ku70 induced by DNA damage interacts with RNA Pol II and promotes the formation of phospho-53BP1 foci to ensure optimal cNHEJAmelie Schellenbauer, Marie-Noelle Guilly, Romain Grall, et al.
Plos One|March 28, 2017
Characteristics of seasonal influenza A and B in Latin America: Influenza surveillance data from ten countriesSaverio Caini, Wladimir J Alonso, Angel Balmaseda, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2013
Discovery of novel HCV inhibitors: synthesis and biological activity of 6-(indol-2-yl)pyridine-3-sulfonamides targeting hepatitis C virus NS4BXiaoyan Zhang, Nanjing Zhang, Guangming Chen, et al.
Biochemical Pharmacology|October 25, 2024
Pharmacological inhibition of cathepsin S and of NSPs-AAP-1 (a novel, alternative protease driving the activation of neutrophil serine proteases)Roxane Domain, Seda Seren, Uwe Jerke, et al.
Immunology and Cell Biology|November 12, 2014
CD3bright signals on γδ T cells identify IL-17A-producing Vγ6Vδ1+ T cellsC Paget, M T Chow, N A Gherardin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2021
Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or OlderLucie Oberic, Frederic Peyrade, Mathieu Puyade, et al.
Pageof 89